Douglas Elliman (DOUG) EBITDA (2021 - 2025)
Douglas Elliman (DOUG) has disclosed EBITDA for 5 consecutive years, with -$10.7 million as the latest value for Q3 2025.
- On a quarterly basis, EBITDA fell 43.39% to -$10.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$37.8 million, a 50.36% increase, with the full-year FY2024 number at -$68.8 million, down 6.71% from a year prior.
- EBITDA was -$10.7 million for Q3 2025 at Douglas Elliman, down from -$5.5 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of $43.2 million in Q2 2021 to a low of -$41.5 million in Q1 2024.
- A 5-year average of -$3.0 million and a median of -$5.5 million in 2025 define the central range for EBITDA.
- Peak YoY movement for EBITDA: tumbled 402.17% in 2023, then surged 87.1% in 2025.
- Douglas Elliman's EBITDA stood at $19.2 million in 2021, then plummeted by 214.02% to -$21.9 million in 2022, then fell by 7.82% to -$23.6 million in 2023, then soared by 31.03% to -$16.3 million in 2024, then soared by 34.46% to -$10.7 million in 2025.
- Per Business Quant, the three most recent readings for DOUG's EBITDA are -$10.7 million (Q3 2025), -$5.5 million (Q2 2025), and -$5.3 million (Q1 2025).